Invention Grant
- Patent Title: Target irrelevant guide RNA for CRISPR
-
Application No.: US17292023Application Date: 2019-10-29
-
Publication No.: US11572554B2Publication Date: 2023-02-07
- Inventor: Yiwei Huang , Maximilian Würstle , Tivadar Mach , Stefan Prause
- Applicant: Siemens Healthcare GmbH
- Applicant Address: DE Erlangen
- Assignee: Siemens Healthcare GmbH
- Current Assignee: Siemens Healthcare GmbH
- Current Assignee Address: DE Erlangen
- Agency: BakerHostetler
- Priority: EP18204790 20181107
- International Application: PCT/EP2019/079478 WO 20191029
- International Announcement: WO2020/094456 WO 20200514
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6806 ; C12N15/11 ; C12N15/10

Abstract:
The present invention relates to a method of obtaining an enriched population of a target polynucleotide using a synthetic single guide RNA (sgRNA) for an sgRNA-guided nucleic acid-binding protein, as well as to a method of obtaining a pool of target-irrelevant synthetic single guide RNAs (sgRNAs) for a sgRNA-guided nucleic acid-binding protein. Also provided is a target polynucleotide and sgRNAs obtainable by the methods of the invention. Further envisaged is a kit comprising a pool of sgRNAs obtainable by the method of the invention, and the use of a pool of sgRNAs obtainable by the methods of the invention.
Public/Granted literature
- US20210355482A1 TARGET IRRELEVANT GUIDE RNA FOR CRISPR Public/Granted day:2021-11-18
Information query